Gamida Cell: StemEx® overview – clinical trials and commercial partners
Yael Margolin, President & CEO of Gamida Cell Ltd., provided this overview of StemEx®. Gamida Cell is currently seeking a strategic partner..
David Bott, Director of Innovation Programs at the Technology Strategy Board UK, presented at last year’s Stem Cells USA & Regenerative..
Yael Margolin, President & CEO of Gamida Cell Ltd., provided this overview of StemEx®. Gamida Cell is currently seeking a strategic partner..
Gaining regulatory and market approval for your stem cell based therapy is merely one of the many challenges facing cell therapy developers...
Manufacturing and supplying a cell therapy throws up numerous challenges, especially when stem cell-based products need to be transported and..
Biogen Idec present their strategy for developing the next generation cell-culture process. The manufacturing of biologics using cell culture..
Leveraging the transformational power of regenerative medicine How will regenerative medicine become part of healthcare in the future? Download..
Advance in aging research - New breakthrough in genetic engineering was able to isolate and purge a category of cells, known as senescent..
Would you carry fat in a grocery bag to Tijuana for the sake of progress and innovation in regenerative medicine? The conservative stance of..
At the Stem Cells USA & Regenerative Medicine Congress there were mixed reviews on whether it is beneficial to circumvent certain..
Attendees at the Stem Cells USA & Regenerative Medicine Congress found Rajan Jethwa's session on the cord blood banking model full of interesting..
According to an Ernst & Young report The DNA of a CFO the CFO’s unique optic across the business, their rare positioning as a purveyor..
© terrapinn holdings ltd. MMX | images courtesy of SXC | terms & conditions | privacy | log in
